Denora Paola S, Santorelli Filippo M, Bertini Enrico
Molecular Medicine and Unit of Neuromuscular and Neurodegenerative Diseases, IRCCS-Children's Hospital Bambino Gesù, Rome, Italy.
Handb Clin Neurol. 2013;113:1899-912. doi: 10.1016/B978-0-444-59565-2.00060-5.
Hereditary spastic paraplegias (HSPs) are genetically heterogeneous Mendelian disorders characterized by spastic gait with stiffness and weakness in the legs and an associated plethora of neurological or extraneurological signs in "complicated" forms. Major advances have been made during the past two decades in our understanding of their molecular bases with the identification of a large number of gene loci and the cloning of a set of them. The combined genetic and clinical information obtained has permitted a new, molecularly-driven classification and an improved diagnosis of these conditions. This represents a prerequisite for better counseling in families and more appropriate therapeutic options. However, further heterogeneity is expected and new insight into the possible mechanisms anticipated.
遗传性痉挛性截瘫(HSPs)是一类具有遗传异质性的孟德尔疾病,其特征为腿部僵硬和无力导致的痉挛步态,以及“复杂”形式下相关的大量神经或神经外体征。在过去二十年中,我们对其分子基础的理解取得了重大进展,鉴定出了大量基因位点并克隆了其中一部分。所获得的遗传和临床信息相结合,使得对这些疾病能够进行新的、基于分子的分类,并改进了诊断方法。这是为家庭提供更好咨询服务以及选择更合适治疗方案的先决条件。然而,预计还会有进一步的异质性,并且有望对可能的机制有新的认识。